Stock USPH U.S. PHYSICAL THERAPY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials U.S. Physical Therapy, Inc.

Equities

USPH

US90337L1089

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-29 pm EDT 		5-day change 1st Jan Change
102 USD +1.36% Intraday chart for U.S. Physical Therapy, Inc. +2.05% +9.49%
Apr. 01 U.S. Physical Therapy, Inc. acquired 50% stake in Nine-Clinic Physical Therapy And Hand Therapy Practice for $16.4 million. CI
Mar. 13 JPMorgan Adjusts U.S. Physical Therapy's Price Target to $117 From $99, Reiterates Overweight Rating MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,461 1,545 1,234 1,054 1,396 1,516 - -
Enterprise Value (EV) 1 1,488 1,545 1,234 1,054 1,390 1,483 1,457 1,429
P/E ratio 46.7 x 48.5 x 39.6 x 32.7 x 46.8 x 36 x 32.9 x 29.3 x
Yield 1% - - - 1.85% 1.73% 1.76% -
Capitalization / Revenue 3.03 x 3.65 x 2.49 x 1.9 x 2.31 x 2.38 x 2.26 x 2.11 x
EV / Revenue 3.09 x 3.65 x 2.49 x 1.9 x 2.3 x 2.33 x 2.18 x 1.99 x
EV / EBITDA 22.1 x 27.3 x 16.6 x 14.3 x 17.9 x 17.9 x 16.4 x 14.6 x
EV / FCF 28.5 x 16.7 x 18.1 x 20.9 x 19.1 x 22.4 x 22 x 20.4 x
FCF Yield 3.51% 5.98% 5.53% 4.77% 5.23% 4.47% 4.55% 4.9%
Price to Book 6.04 x 5.6 x 4.17 x - - - - -
Nbr of stocks (in thousands) 12,774 12,850 12,912 13,002 14,987 15,068 - -
Reference price 2 114.4 120.2 95.55 81.03 93.14 102.0 102.0 102.0
Announcement Date 2/27/20 2/25/21 2/24/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 482 423 495 553.1 604.8 637 669.4 717.7
EBITDA 1 67.28 56.52 74.34 73.66 77.72 82.86 88.67 97.88
EBIT 1 67.42 52.41 70.65 56.8 68.06 73.13 80.14 86.51
Operating Margin 13.99% 12.39% 14.27% 10.27% 11.25% 11.48% 11.97% 12.05%
Earnings before Tax (EBT) 1 70.91 65.51 73.2 55.57 49.38 67.88 72.2 73
Net income 1 40.04 35.19 40.83 32.16 28.24 43.4 47.64 53.04
Net margin 8.31% 8.32% 8.25% 5.81% 4.67% 6.81% 7.12% 7.39%
EPS 2 2.450 2.480 2.410 2.476 1.990 2.837 3.097 3.480
Free Cash Flow 1 52.26 92.36 68.2 50.29 72.68 66.24 66.28 70
FCF margin 10.84% 21.84% 13.78% 9.09% 12.02% 10.4% 9.9% 9.75%
FCF Conversion (EBITDA) 77.67% 163.41% 91.74% 68.27% 93.52% 79.93% 74.74% 71.51%
FCF Conversion (Net income) 130.52% 262.42% 167.04% 156.38% 257.39% 152.63% 139.13% 131.98%
Dividend per Share 2 1.140 - - - 1.720 1.760 1.795 -
Announcement Date 2/27/20 2/25/21 2/24/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 125.9 129.8 131.7 140.7 139.6 141.2 148.5 151.5 150 154.8 153.4 160.6 159.5 163.4 161.1
EBITDA 1 19.94 17 17.86 21.35 16.99 17.85 18.85 21.67 18.59 18.99 18.53 22.68 20.26 21.41 19.45
EBIT 1 16.93 16.46 15.03 20.08 14.9 6.794 17 20.06 15.88 15.44 15.65 20.6 17.96 18.82 16.61
Operating Margin 13.45% 12.68% 11.41% 14.28% 10.67% 4.81% 11.45% 13.24% 10.59% 9.97% 10.21% 12.82% 11.26% 11.52% 10.31%
Earnings before Tax (EBT) 1 17.94 18.39 15.48 19.5 16.04 4.56 - 19.1 15.78 - 13 19 15 17 -
Net income 1 10.01 10.21 8.799 11.2 9.557 2.607 7.41 10.92 9.254 0.656 8.759 12.54 10.22 11.88 8.28
Net margin 7.95% 7.87% 6.68% 7.96% 6.85% 1.85% 4.99% 7.21% 6.17% 0.42% 5.71% 7.81% 6.41% 7.27% 5.14%
EPS 2 0.6600 0.7300 0.6700 0.8700 0.7200 0.2000 0.5800 0.6400 0.5100 0.0438 0.5933 0.8267 0.6733 0.7467 0.5400
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/24/22 5/5/22 8/4/22 11/2/22 2/23/23 5/3/23 8/8/23 11/7/23 2/28/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 27.5 - - - - - - -
Net Cash position 1 - - - - 6.14 32.9 59.3 86.8
Leverage (Debt/EBITDA) 0.4093 x - - - - - - -
Free Cash Flow 1 52.3 92.4 68.2 50.3 72.7 66.2 66.3 70
ROE (net income / shareholders' equity) 17.6% 13.6% 14.3% - 9.16% 8.05% 9.8% 10.2%
ROA (Net income/ Total Assets) 7.98% 6.09% 6.08% - 3.91% 4.75% 4.88% 5.23%
Assets 1 501.7 577.6 671.9 - 722.4 914.4 976.9 1,015
Book Value Per Share 18.90 21.50 22.90 - - - - -
Cash Flow per Share 2 - - - - 5.780 5.540 5.840 -
Capex 1 10.2 7.64 8.2 8.25 9.29 9.64 9.85 9.75
Capex / Sales 2.11% 1.81% 1.66% 1.49% 1.54% 1.51% 1.47% 1.36%
Announcement Date 2/27/20 2/25/21 2/24/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for U.S. Physical Therapy, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
100.6 USD
Average target price
119.3 USD
Spread / Average Target
+18.58%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
U.S. PHYSICAL THERAPY, INC. Stock U.S. Physical Therapy, Inc.
+9.49% 1.52B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-17.07% 16.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+3.60% 12.44B
IHH HEALTHCARE Stock IHH Healthcare
+5.64% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+4.63% 10.79B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+25.36% 8.26B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-0.21% 7.68B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+22.18% 7.06B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+5.77% 6.67B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+52.00% 4.66B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. USPH Stock
  4. Financials U.S. Physical Therapy, Inc.